You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Rhinology
Connecting Type 2 Inflammation to CRSwNP
Prof. Claus Bachert describes how type 2 inflammation drives CRSwNP.
MD, PhD
Claus Bachert
Learning objectives
- Differentiate roles of IL-4, IL-13, and IL-5 as drivers of the type 2 inflammation underlying CRSwNP and type 2 biomarkers
- Learn about key and central roles of IL-4 and IL-13 in type 2 inflammation, and pathophysiological consequences in CRSwNP (barrier dysfunction, remodeling)
Description
Claus Bachert, MD, PhD, describes how type 2 inflammation leads to the pathological features and clinical consequences of uncontrolled CRSwNP.
Tags
MAT-US-2205777 v4.0 - P Exp. Date 04/01/2026
About this expert
Rhinology
Claus Bachert
MD, PhD
Former Chief of the Clinic and Professor | University Hospital of Ghent, Belgium
See author’s profileRelated resources
